If you have a common aging-related enlargement of the prostate, a condition called BPH, you may have some of the problems that come with it. These are problems like more frequent nighttime peeing, more urge to pee during the day, difficulty starting urine flow, inability to completely empty your bladder, even urinary tract infections that keep reading

An essential part of planning treatment for prostate cancer (PCa) is determining its size and location. Where and how big is it? If the tumor is found early when it is small and contained within the gland, it is called localized. In this case, the patient is a candidate for a local treatment with curative keep reading

When a patient is told, “You have prostate cancer,” it’s not a simple one-size-fits-all diagnosis. The doctor will then give the patient an idea of how severe his cancer is. If his prostate cancer (PCa) is still localized (that is, contained within the gland), the doctor will specify if it is low, intermediate, or high keep reading

The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into surgery or radiation. Today’s terminology includes words that might have been meaningless a decade ago, e.g. indolent cancer, very low risk disease, and focal disease are all consistent with the growing movement toward AS. keep reading

If you’re a real estate developer planning to build a new house, you start with the groundwork—literally. Before you start excavating, you have analysts determine the basics: the type of soil, the water table, and any flood risk. You want to know the important foundation factors that help predict the future stability of the construction. keep reading

We’ve said it before and we’ll say it again: exercise offers better outcomes for prostate cancer patients. This time, we’re basing our advice on an exciting development in the field of cancer research. Oncology, or the medical specialty dealing with cancer, is increasingly interested in the relationship between exercise and cancer survival. A noted authority keep reading

The interpretation of medical images is “a task that lies at the heart of the radiologist’s work.”[i] In fact, the human element—a radiologist’s eyes and brain—is just as important as what a high resolution, 3- dimensional image depicts. Imaging types include x-ray, MRI, CT scan, ultrasound and PET scan, but no matter how advanced the keep reading

Once a popular prostate cancer treatment, brachytherapy has seen a sharp decline—and new research may reveal why. A study found that half of patients experienced cancer recurrence, challenging its long-term effectiveness. With evolving treatment options, it’s crucial to weigh the risks and benefits before choosing a path... keep reading

Can a diet rich in omega-3s slow prostate cancer growth? A new UCLA study suggests that men with early-stage prostate cancer who followed a high omega-3, low omega-6 diet—plus fish oil supplements—saw a significant drop in a key cancer progression marker. With promising implications for Active Surveillance, this research may redefine prostate health strategies. keep reading

Radiation for prostate cancer can come with long-term sexual side effects that aren’t always discussed upfront. While erectile dysfunction is well known, new research highlights issues with ejaculation, including reduced volume and discomfort. Patients deserve full transparency about these risks before choosing treatment. Learn why informed decision-making is crucial. keep reading